BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.90
-0.03 (-3.23%)
Open$0.92
Previous Close$0.93
Day High$0.92
Day Low$0.89
52W High$10.08
52W Low$0.57
Volume—
Avg Volume46.7K
Market Cap5.27M
P/E Ratio—
EPS$-1.65
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+747.9% upside
Current
$0.90
$0.90
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.89M | 1.16M | 1.19M |
| Net Income | -7,564,764 | -117,803 | -121,826 |
| Profit Margin | -401.3% | -10.2% | -10.2% |
| EBITDA | -8,768,400 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.68 | -0.45% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $412.84 | -1.20% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.12 | -0.01% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $508.33 | -1.57% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.64 | -0.29% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.29 | +0.07% | 35.2 | 28.41B |